Results 211 to 220 of about 10,648,550 (267)

Consolidation of Sequential Planning

Vikbladh OM, Russek EM, Burgess N.
europepmc   +1 more source

Delineating anticipatory arousal from reward consumption: evaluating fixed-intervals in cocaine seeking-taking response chains. [PDF]

Psychopharmacology (Berl)
Leonard MZ, Miczek KA, Covington HE.
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

A Comparative Analysis of Physical and Mobile Phone Tracing in Clinical Trials in Lilongwe, Malawi. [PDF]

Malawi Med J
Mancuso N, Kumwenda W, Chome N, Singogo E, Hoffman I, Kamwendo D, Mofolo I, Martinson F, Chagomerana MB, Werekhwe G, Hosseinipour MC.   +10 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Oral Angiolymphoid Hyperplasia With Eosinophilia Exhibiting Cutaneous-Type Histopathologic Features: Clinical Regression Following Hormonal Withdrawal and a 50-Year Review. [PDF]

J Cutan Pathol
Jesus PVS, Santos LC, Aciole GTDS, Cunha JLS, Lonni N, Costa MADS, Rivero ERC, Gondak R, Albuquerque-Júnior RLC.   +8 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

<i>KMT2B</i>-related disorders in Austria: clinical features and long-term outcome after deep brain stimulation. [PDF]

Front Neurol
Indelicato E, Siegert S, Langer A, Hussl A, Mahlknecht P, Mair K, Eberl A, Zech M, Schmidt WM, Boesch S.   +9 more
europepmc   +1 more source

Ways of Coping with Stress in Women Diagnosed with Breast Cancer: A Preliminary Study. [PDF]

Healthcare (Basel)
Wypych-Ślusarska A, Ociepka S, Krupa-Kotara K, Głogowska-Ligus J, Oleksiuk K, Słowiński J, Yanakieva A.   +6 more
europepmc   +1 more source

Inflammatory Bowel-Like Disease with Ileocolic and Perianal Involvement Induced by Ocrelizumab: A Case Report. [PDF]

Case Rep Gastroenterol
Soares C, Canastra A, Domingues Â, Carvalho AC, Martins D, Sousa P, Cancela E, Silva A, Ministro P.   +8 more
europepmc   +1 more source